Clinical Observation On Application Of State Medicine Theory And Method To Treat Type Of Deficiency Of The Kidney Of Depression

objective:With the rapid economic development of modern society, all aspects of an increasingly competitive, it is the pressure surge in the incidence of depression has increased steadily, the present study is in a state of medical theory to guide the state medical treatment and Morinda officinalis oligosaccharides encapsulated phase combination used in mild to moderate depression, kidney deficiency and improve the clinical symptom improvement rate, restore the normal state of body, mental state and social function, to provide new ideas and methods for the treatment of depression.method:The 44 cases of depression patients met the inclusion criteria were randomly divided into the treatment group and the state medical medicine control group, falling 4 cases,40 cases finally included in the statistics. Combined treatment group Morinda oligosaccharide capsule in the treatment regimen according to the state medical theory developed state of the control group taking only Morinda officinalis oligosaccharides Capsule. Observation time of eight weeks, respectively, prior to enrollment (baseline),2 weeks, 4 weeks,6 weeks,8 weeks after the assessment of the Hamilton Depression Scale (HAMD), TCM kidney deficiency syndrome quantitative score and Clinical Global Impression Scale (CGI) to score changes. All data SSPS22.0 and SAS9.2 software for statistical analysis.Results:Application state treatment program combines Morinda oligosaccharidecapsule treatment group achieved good results:In the Hamilton Depression Scale (HAMD) assessment, treatment and control group scores than before treatment decreased, but the treatment group was significantly higher reduction rate in the control group and the treatment group in depression, symptoms, hypochondria and other projects score was significantly lower than before treatment (P＜0.05), after treatment scored significantly lower than the control group; TCM deficiency Syndrome rating scale quantization, the treatment group and control group scores decreased than before treatment, the treatment group was significantly lower than the control group in depression (TCM), and so on tenterhooks scores significantly lower than before treatment (P＜0.05), and after treatment scores; in the clinical Global impression scale (CGI) scores, the treatment group was significantly better than the control group (P＜0.05). Could improve treatment, two weeks after the symptoms of depression, but the treatment group at each time point in the treatment efficacy than the control group, indicating that the treatment group from the onset time is earlier than the control group and the treatment group can exert a strong therapeutic effect. Above shows the application state treatment program combines Morinda oligosaccharide capsule in the treatment of mild to moderate depression and kidney deficiency compared to taking only Morinda officinalis oligosaccharides capsule treatment has certain advantages.conclusion:Application state medical theory and method combined with Morinda oligosaccharides with mild to moderate kidney capsule type of depression symptoms improve clinical treatment, to restore the role of psychological and social function is significant, clinical application value.